ArticleCell death & disease2023

Co-targeting HSP90 alpha and CDK7 overcomes resistance against HSP90 inhibitors in BCR-ABL1+ leukemia cells.

Melina Vogt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.